From the FDA: FDA Issues Final Rule on Drug Products Containing Colloidal Silver

Journal of the American Osteopathic Association, The - United States
doi 10.7556/jaoa.1999.99.9.459d
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Osteopathic Association

Related search

From the FDA: Epilepsy Drug Approved

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

FDA Issues Draft Guidance on MRD Testing

Cancer Discovery
Oncology
2018English

2017 FDA Drug Approvals

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2018English

OxyContin, the FDA, and Drug Control

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2014English

From the FDA: FDA Warns About Sleep Aids

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1999English

FDA Tightens Its Grip on Drug Regulation

BMJ
2007English

Clinicians Perspective of the New Pregnancy and Lactation Labeling Final Rule(PLLR): Results From a FDA/ AAAAI Survey

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

From the FDA: Panel Recommends Approval of Drug for ALS

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

From the FDA: Mislabeling of Drug for Kaposi's Sarcoma Rectified

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy